We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT02201303
Brief Title: Evaluation of Danirixin (GSK1325756) Inhibition of CD11b Cell Surface Expression

First Submitted : January 9, 2014
First Submitted that Met QC Criteria : July 24, 2014
First Posted : July 28, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : May 5, 2017
Last Update Posted : May 9, 2017